)
Edge12 Jun 2026
Set in Stone: The Story of Richemont
From a South African tobacco company to Cartier, a deep dive into how Richemont built one of the world's leading hard luxury empires.
Nektar Therapeutics
Nektar Therapeutics (NKTR) investor relations material
Nektar Therapeutics AGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.AGM 2026 summary4 Jun, 2026
Opening remarks and agenda
Meeting opened by Vice President, Legal and Corporate Counsel, with board members, executive team, and auditors present.
Formal business included voting on four proposals, followed by business highlights and a Q&A session.
Shareholder proposals
Four proposals: election of one director, amendment to increase shares in the 2017 Performance Incentive Plan, ratification of auditors, and a non-binding advisory vote on executive compensation.
Overview of voting outcomes
All four proposals were approved by a majority of shares voted, including director election, plan amendment, auditor ratification, and executive compensation.
Final results to be published in a Form 8-K within four business days.
Clarify REZPEG collaboration vs licensing model
REZPEG differentiation from IL-13 inhibitors
Indication strategy for NKTR-0166 bispecific
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Nektar Therapeutics
- Global phase III trials for a novel Treg agonist target broad immune diseases, with first data in 2028.NKTR
Jefferies Global Healthcare Conference 20263 Jun 2026 - REZPEG advances to Phase 3 after strong Phase 2 data and $476M raised for late-stage trials.NKTRQ4 202515 May 2026
- Strong cash, narrowed losses, and positive clinical data drive late-stage program progress.NKTRQ1 202611 May 2026
- Annual meeting seeks approval for director, incentive plan shares, auditor, and say-on-pay.NKTRProxy filing24 Apr 2026
- Proxy covers director election, equity plan amendment, auditor ratification, and say-on-pay.NKTRProxy filing24 Apr 2026
- Rezpegaldesleukin showed durable efficacy and strong safety at 52 weeks, supporting first-line use.NKTRStudy update20 Apr 2026
- REZPEG demonstrates durable efficacy and safety, setting new standards in immune-mediated diseases.NKTRTD Cowen 46th Annual Health Care Conference4 Mar 2026
- Durable efficacy and deepening responses maintained with strong safety over 52 weeks.NKTRStudy result10 Feb 2026
- REZPEG shows strong efficacy in atopic dermatitis, with pivotal data expected in early 2025.NKTRGoldman Sachs 45th Annual Global Healthcare Conference1 Feb 2026
Next Nektar Therapeutics earnings date
Q2 20266 Aug, 2026
Nektar Therapeutics
Next Nektar Therapeutics earnings date
Q2 20266 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage